The serum concentration of Atorvastatin can be increased when it is combined with Lepirudin. The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin. The risk or severity of adverse effects can be increased when Modafinil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Irinotecan is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nicergoline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Bortezomib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Doxorubicin is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Tolazamide. The serum concentration of Atorvastatin can be increased when it is combined with Elafin. The serum concentration of Atorvastatin can be increased when it is combined with Benazepril. The risk or severity of adverse effects can be increased when Ceritinib is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Warfarin. The serum concentration of Atorvastatin can be increased when it is combined with Racecadotril. The risk or severity of adverse effects can be increased when Repaglinide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Chymostatin. The risk or severity of adverse effects can be increased when Nimodipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ombitasvir. The risk or severity of adverse effects can be increased when Ziconotide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Bepridil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Caspofungin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tamoxifen is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Bosentan. The serum concentration of Prucalopride can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Felodipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Aluminium. The risk or severity of adverse effects can be increased when Docetaxel is combined with Atorvastatin. The serum concentration of Metoprolol can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Troleandomycin is combined with Atorvastatin. The serum concentration of Thioridazine can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Capsaicin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Saquinavir. The risk or severity of adverse effects can be increased when Lidocaine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Clomifene is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Glyburide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Olaparib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Oxymetholone is combined with Atorvastatin. The serum concentration of Ibrutinib can be increased when it is combined with Atorvastatin. The metabolism of Atorvastatin can be decreased when combined with Trimethoprim. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Ketoconazole. The risk or severity of adverse effects can be increased when Nicardipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Teniposide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Spironolactone. The risk or severity of adverse effects can be increased when Clindamycin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Fluconazole. The serum concentration of Atorvastatin can be increased when it is combined with Bivalirudin. The risk or severity of adverse effects can be increased when Clotrimazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Daptomycin. The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Saxagliptin. The serum concentration of Atorvastatin can be increased when it is combined with Ribociclib. The serum concentration of Atorvastatin can be increased when it is combined with Alpha-1-proteinase inhibitor. The risk or severity of adverse effects can be increased when Eperisone is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Magnesium Trisilicate. The risk or severity of adverse effects can be increased when Flunarizine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Delavirdine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Gallopamil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Pimozide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Vinpocetine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Nitroaspirin. The serum concentration of Atorvastatin can be increased when it is combined with Thiorphan. The risk or severity of adverse effects can be increased when Fosaprepitant is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Bismuth Subcitrate. The serum concentration of Atorvastatin can be increased when it is combined with Ritonavir. The metabolism of Atorvastatin can be decreased when combined with Rosiglitazone. The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Atorvastatin. Acipimox may increase the myopathic rhabdomyolysis activities of Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with GM6001. The risk or severity of adverse effects can be increased when Fidaxomicin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Darexaban. The risk or severity of adverse effects can be increased when Niludipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nefazodone is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Dabrafenib. The risk or severity of adverse effects can be increased when Nilvadipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Mirtazapine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sirolimus is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Glimepiride. The serum concentration of Afatinib can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Cholesterol. The metabolism of Atorvastatin can be decreased when combined with Pioglitazone. The risk or severity of adverse effects can be increased when Risperidone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lamotrigine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Venlafaxine is combined with Atorvastatin. The serum concentration of Naloxegol can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Aluminum hydroxide. Atorvastatin may increase the hypoglycemic activities of Gliquidone. The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid. The serum concentration of Atorvastatin can be increased when it is combined with Enalaprilat. The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Danazol. The risk or severity of adverse effects can be increased when Histamine is combined with Atorvastatin. Colchicine may increase the myopathic rhabdomyolysis activities of Atorvastatin. Atorvastatin may increase the myopathic rhabdomyolysis activities of Trabectedin. The serum concentration of Atorvastatin can be increased when it is combined with Daclatasvir. The risk or severity of adverse effects can be increased when Paclitaxel is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ranitidine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Isavuconazonium is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Methazolamide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Enasidenib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Irbesartan is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sorafenib is combined with Atorvastatin. The serum concentration of Silodosin can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nilotinib is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Acetohexamide. The serum concentration of Atorvastatin can be increased when it is combined with Batimastat. The risk or severity of adverse effects can be increased when Cilnidipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Candoxatrilat. The risk or severity of adverse effects can be increased when Lapatinib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ranolazine. The risk or severity of adverse effects can be increased when Etoposide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Letaxaban. The serum concentration of Atorvastatin can be increased when it is combined with Enalapril. The risk or severity of adverse effects can be increased when Sertaconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Zafirlukast is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ixazomib. The risk or severity of adverse effects can be increased when Raloxifene is combined with Atorvastatin. The serum concentration of Ledipasvir can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Azimilide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Perhexiline is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Tromethamine. The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Cholestyramine. Bezafibrate may increase the myopathic rhabdomyolysis activities of Atorvastatin.